At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 29 enrolled
Drug / intervention
Cryoablationprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Cryoablation for the Palliation of Painful Bone Metastases
In Brief
A Phase 1 clinical trial evaluating Cryoablation for Pain and Neoplasm Metastasis. Completed, enrolled 29 participants across 4 sites in 3 countries.
Detailed Summary
This study will evaluate the safety and efficacy of cryoablation therapy for relief of pain associated with metastatic bone tumors.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain, Neoplasm Metastasis
CountriesCanada, France, United States
Collaborators--
Timeline
Phase 1CompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedOct 2011
Enrollment StartNov 2011
Primary CompletionApr 2015
TodayJul 2026
First PostedOct 28, 2011
Enrollment StartNov 1, 2011
Primary CompletionApr 1, 2015
TodayJul 2, 2026
Enrollment to primary: 3.4 yearsPosted 14.7 years ago
Interventions
Cryoablationprocedure
For cryoablation in the palliation of painful bone metastases, subject preparation, anesthesia, intra-operative monitoring, and postoperative management are identical to those of standard cryoablation routinely performed at all clinical centers participating in this study and are at the discretion of the investigator.